Clinical Research Directory

A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

Sponsor: Tianjin Medical University Cancer Institute and Hospital

Summary

This study is a Phase I, open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Official title: The Phase I, Open-label, Single-arm Clinical Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Patients With Advanced Solid Tumors

Key Details

Conditions

Interventions

Locations (1)